Top Markets
Coin of the day
Eurobio Scientific Société anonyme Eurobio Scientific Société anonyme

Eurobio Scientific Société anonyme

ALERS
Rang in Aktien #10859
Eurobio Scientific Société anonyme designs, develops, and commercializes... Eurobio Scientific Société anonyme designs, develops, and commercializes specialty diagnostic products in the areas of transplantation, infectious diseases, life-science, and cancer. The company offers Tetanus Quick Stick, a test that is used in emergency clinics for the determination of the tetanus vaccination status of a patient; and commercializes cell culture media, molecular biology reagents, and proprietary antibodies. Its in-house development products include the BJI InoPlex, a multiplex serological test used for the diagnosis of prosthetic joint infections; EBX-044 PCR test to enable the identification of SARS-CoV-2 variants; and licensed products comprise AlloMap, a gene-expression profiling based blood test for the surveillance of heart-transplant patients. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
Aktienkurs
$25.15
Marktkapitalisierung
$253.18M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-12.08%
Land
FR
Handel Eurobio Scientific Société anonyme (ALERS)

Kategorie

P/B-Verhältnis für Eurobio Scientific Société anonyme (ALERS)
P/B-Verhältnis zum July 2026 TTM: 1.21
Laut den neuesten Finanzberichten und dem Aktienkurs von Eurobio Scientific Société anonyme beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 1.21. Am Ende des Jahres 2023 lag das P/B-Verhältnis bei 1.05.
P/B-Verlauf für Eurobio Scientific Société anonyme von 2007 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
2026 (TTM) 1.21 -16.37%
2024 1.45 38.22%
2023 1.05 -13.35%
2022 1.21 -33.86%
2021 1.83 2.97%
2020 1.77 26.76%
2019 1.40 38.00%
2018 1.01 -22.89%
2017 1.31 -33.66%
2016 1.98 35.47%
2015 1.46 11.74%
2014 1.31 -28.33%
2013 1.83 38.37%
2012 1.32 -51.04%
2011 2.70 -24.43%
2010 3.57 -12.02%
2009 4.06 -46.56%
2008 7.59 18.64%
2007 6.40 0.00%
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
3.0429 150.92%
US
5.2455 332.55%
US
2.0273 67.17%
IE
2.4503 102.05%
US
5.0733 318.35%
US